Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
JAMA|December 22, 2025
An mHealth (Mobile Health) Intervention for Smoking Cessation in People With Tuberculosis: A Cluster Randomized Clinical TrialMaham Zahid, Fahmidur Rahman, Mahmoud Danaee, et al.
Hospital Pediatrics|June 2, 2021
Physiologic Monitor Alarm Burden and Nurses' Subjective Workload in a Children's HospitalIrit R Rasooly, Andrew S Kern-Goldberger, Rui Xiao, et al.
The Lancet Regional Health. Southeast Asia|May 13, 2026
Cost-effectiveness of a mTB-Tobacco intervention for smoking cessation in people with tuberculosis: an economic evaluation of a cluster randomised controlled trialJinshuo Li, Steve Parrott, Maham Zahid, et al.
Journal of the American Medical Informatics Association : JAMIA|October 19, 2021
Alert burden in pediatric hospitals: a cross-sectional analysis of six academic pediatric health systems using novel metricsEvan W Orenstein, Swaminathan Kandaswamy, Naveen Muthu, et al.
Interventional Cardiology (London, England)|August 24, 2023
Angiographic and Procedural Characteristics in Frail Older Patients with Non-ST Elevation Acute Coronary SyndromeBenjamin Beska, Hanna Ratcovich, Alan Bagnall, et al.
Health Research Policy and Systems|April 19, 2022
Scaling up tobacco cessation within TB programmes: findings from a multi-country, mixed-methods implementation studyHelen Elsey, Zunayed Al Azdi, Shophika Regmi, et al.
Addiction (Abingdon, England)|April 21, 2018
The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trialOmara Dogar, Deepa Barua, Melanie Boeckmann, et al.
Hospital Pediatrics|June 4, 2023
Opportunities for Diagnostic Improvement Among Pediatric Hospital ReadmissionsMorgan Congdon, Bridget Rauch, Bryn Carroll, et al.
BMJ Open|August 26, 2022
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trialJinshuo Li, Steve Parrott, Ada Keding, et al.
The Lancet. Global Health|October 18, 2020
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialOmara Dogar, Ada Keding, Rhian Gabe, et al.
Pageof 9